Concepedia

Brian A. Oldham

BA

Statistics

Publications

8

Citations

742

H-Index

8

Active since

2000

Affiliations

Eli Lilly (United States)(Current)

Ligand Pharmaceuticals (United States)

Brian A. Oldham is an author at Eli Lilly (United States) specializing in pharmacology, drug discovery, and drug design.

Publications per year

2000–2006

8

Publications

8

Antidiabetic Action of a Liver X Receptor Agonist Mediated By Inhibition of Hepatic Gluconeogenesis

Guoqing Cao, Liang Yu, Carol L. Broderick et al. · Journal of Biological Chemistry · 2003 · 293 citations · Full text

, , +17

Profiling of Zucker diabetic fatty rats in their progression to the overt diabetic state

Garret J. Etgen, Brian A. Oldham · Metabolism · 2000 · 170 citations

, , +13

A Tailored Therapy for the Metabolic Syndrome

Garret J. Etgen, Brian A. Oldham, W. Thomas Johnson et al. · Diabetes · 2002 · 105 citations · Full text

, , +17

Design and Synthesis of 2-Methyl-2-{4-[2-(5-methyl-2-aryloxazol- 4-yl)ethoxy]phenoxy}propionic Acids:  A New Class of Dual PPARα/γ Agonists

Dawn A. Brooks, Garret J. Etgen, Christopher J. Rito et al. · Journal of Medicinal Chemistry · 2001 · 68 citations · Full text

, , +13

Design and Synthesis of α-Aryloxy-α-methylhydrocinnamic Acids:  A Novel Class of Dual Peroxisome Proliferator-Activated Receptor α/γ Agonists

Yanping Xu, Christopher J. Rito, Garret J. Etgen et al. · Journal of Medicinal Chemistry · 2004 · 44 citations · Full text

, , +14

1–5 of 8